Lung adenocarcinoma, immunotherapy, cryoablation
Showing 1 - 25 of >10,000
Local and Peripheral Immune Responsive Landscape Induced by
Not yet recruiting
- Lung Adenocarcinoma
- Local Cryoablation
- (no location specified)
Oct 24, 2023
NSCLC Trial in Shanghai (Toripalimab, Cryoablation)
Not yet recruiting
- Non-small Cell Lung Cancer
- Toripalimab
- Cryoablation
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 7, 2023
Lung Adenocarcinoma, Cryotherapy Effect Trial in Bordeaux (Cryoablation, Pembrolizumab, Pemetrexed)
Recruiting
- Lung Adenocarcinoma
- Cryotherapy Effect
- Cryoablation
- +3 more
-
Bordeaux, Gironde, FranceInstitut Bergonié
Oct 29, 2021
Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,
Completed
- Metastatic Prostatic Adenocarcinoma
- Opdivo Injectable Product
- +3 more
-
Lancaster, California
- +1 more
Jun 15, 2022
I3LUNG: Integrative Science, Intelligent Data Platform for
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
-
Chicago, Illinois
- +3 more
Sep 13, 2022
ALK Gene Mutation, Lung Adenocarcinoma, Immunotherapy Trial in Changsha (Pembrolizumab Combined With Bevacizumab and
Not yet recruiting
- ALK Gene Mutation
- +2 more
- Pembrolizumab Combined With Bevacizumab and Chemotherapy
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jul 14, 2022
Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (biological, procedure,
Recruiting
- Lung Adenocarcinoma
- +2 more
- Ipilimumab
- +5 more
-
Conroe, Texas
- +4 more
May 25, 2022
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +14 more
- ELI-002 7P
- (no location specified)
Feb 3, 2023
Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston
Recruiting
- Lung Atypical Carcinoid Tumor
- +13 more
- Nivolumab
- Stereotactic Body Radiation Therapy
-
Conroe, Texas
- +2 more
Feb 25, 2022
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, NSCLC Stage IV Trial in Australia, United States (IMU-201
Recruiting
- Non Small Cell Lung Cancer
- +5 more
- IMU-201 (administered as PD1-Vaxx)
-
Phoenix, Arizona
- +5 more
Jan 19, 2022
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023
A Multicenter Cancer Biospecimen Collection Study
Recruiting
- Cancer of Head and Neck
- +10 more
- OncoPrism™ assay
-
San Francisco, CaliforniaCurebase
Mar 8, 2022
Advanced Lung Adenocarcinoma, Advanced Lung Adenosquamous Carcinoma, Advanced Lung Non-Small Cell Carcinoma Trial in United
Recruiting
- Advanced Lung Adenocarcinoma
- +10 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +98 more
Feb 2, 2023
Advanced LKB1-inactive Lung Adenocarcinoma Trial in Milan (Metformin Hydrochloride, Cisplatin, Carboplatin)
Recruiting
- Advanced LKB1-inactive Lung Adenocarcinoma
- Metformin Hydrochloride
- +5 more
-
Milan, ItalyMarina Chiara Garassino
Nov 12, 2020
Advanced Liver Cancers Trial (DC-CIK)
Not yet recruiting
- Advanced Liver Cancers
- DC-CIK
- (no location specified)
Nov 11, 2022
CT-based Radiomic Algorithm for Assisting Surgery Decision and
Recruiting
- Predictive Cancer Model
- +2 more
- Radiomic Algorithm
-
Guangzhou, Guangdong, China
- +2 more
Jun 29, 2020
Prognosis of Lung Cancer Immunotherapy
Not yet recruiting
- Lung Cancer
- (no location specified)
May 31, 2023
NSCLC, Immunotherapy Trial in Ann Arbor (Dexamthasone)
Terminated
- Non-Small Cell Lung Cancer
- Immunotherapy
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System, Ann Arbor, MI
Jan 6, 2023
Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)
Recruiting
- Ovarian Cancer
- +10 more
-
West Hollywood, California
- +27 more
Jun 27, 2022
Advanced NSCLC Trial in New York (ERBOKRYO® CA - Cryosurgical Unit with Flexible ERBECRYO Probe, 1.9 mm outer diameter (ERBE
Recruiting
- Advanced Non-small Cell Lung Cancer
- ERBOKRYO® CA - Cryosurgical Unit with Flexible ERBECRYO Probe, 1.9 mm outer diameter (ERBE Inc., Tubingen, Germany)
-
New York, New YorkNYU Langone Health
Jun 24, 2022
Metastatic Pancreatic Adenocarcinoma Trial in United States (Nivolumab (Cohort A), Ipilimumab (Cohort A and B),
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Nivolumab (Cohort A)
- +4 more
-
Los Angeles, California
- +6 more
Aug 8, 2022
Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)
Not yet recruiting
- Metastatic Melanoma
- Skin Cancer
- Ipilimumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Mar 9, 2023
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
Lung Cancer Trial (Percutaneous or transbronchial argon-helium cryoablation)
Not yet recruiting
- Lung Cancer
- Percutaneous or transbronchial argon-helium cryoablation
- (no location specified)
Apr 7, 2023